These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16904256)

  • 1. Detection of Escherichia coli 16S RNA and cytotoxic necrotizing factor 1 gene in benign prostate hyperplasia.
    Bergh J; Marklund I; Thellenberg-Karlsson C; Grönberg H; Elgh F; Alexeyev OA
    Eur Urol; 2007 Feb; 51(2):457-62; discussion 462-3. PubMed ID: 16904256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the presence of bacterial 16S RNA in prostate specimens taken during transurethral resection of prostate and subsequent risk of prostate cancer (Sweden).
    Alexeyev O; Bergh J; Marklund I; Thellenberg-Karlsson C; Wiklund F; Grönberg H; Bergh A; Elgh F
    Cancer Causes Control; 2006 Nov; 17(9):1127-33. PubMed ID: 17006718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction.
    Hochreiter WW; Duncan JL; Schaeffer AJ
    J Urol; 2000 Jan; 163(1):127-30. PubMed ID: 10604329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of immunomodulator secretion in urinary samples in response to infection by alpha-hemolysin and CNF1 bearing uropathogenic Escherichia coli.
    Real JM; Munro P; Buisson-Touati C; Lemichez E; Boquet P; Landraud L
    Cytokine; 2007 Jan; 37(1):22-5. PubMed ID: 17382555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for prostatic inflammation extent and infection in benign prostatic hyperplasia.
    Yi FX; Wei Q; Li H; Li X; Shi M; Dong Q; Yang YR
    Asian J Androl; 2006 Sep; 8(5):621-7. PubMed ID: 16751994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacterial content of the enucleated prostate gland].
    Soler Soler JL; Hidalgo Domínguez MR; Zuluaga Gómez A; Martínez Torres JL; Lardelli Claret P; Liébana Ureña J; Saharour G
    Arch Esp Urol; 1999 Oct; 52(8):823-34. PubMed ID: 10589113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of SelB in the expression of cytotoxic necrotizing factor 1 in Escherichia coli.
    Yu H; Kim KS
    FEBS Lett; 2011 Jun; 585(12):1934-40. PubMed ID: 21570972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z; Wenlu S
    Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active cytotoxic necrotizing factor 1 associated with outer membrane vesicles from uropathogenic Escherichia coli.
    Kouokam JC; Wai SN; Fällman M; Dobrindt U; Hacker J; Uhlin BE
    Infect Immun; 2006 Apr; 74(4):2022-30. PubMed ID: 16552031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transurethral resection of the prostate (TURP)--in the treatment of benign prostatic hypertrophy (BPH) in Mekelle, Ethiopia.
    Alemu MH
    Ethiop Med J; 2009 Jan; 47(1):65-9. PubMed ID: 19743783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic necrotizing factor 1 (CNF1) induces an inflammatory response in the urinary tract in vitro but not in vivo.
    Hertting O; Chromek M; Slamová Z; Kádas L; Söderkvist M; Vainumäe I; Tallvik T; Jacobson SH; Brauner A
    Toxicon; 2008 Jun; 51(8):1544-7. PubMed ID: 18471840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence and characterization of uropathogenic Escherichia coli producing cytotoxic necrotizing factor type 1 (CNF1) in the center of Tunisia].
    Denden I; Mahdouani K; Bakhrouf A
    Ann Biol Clin (Paris); 2004; 62(3):311-7. PubMed ID: 15217764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and analysis of the regulatory region R&R* with the cnf1 gene encoding the cytotoxic necrotizing factor type 1 that closely links to the lux regulon of Vibrio fischeri.
    Lin JW; Chen LM; Chen HY; Weng SF
    Biochem Biophys Res Commun; 1998 Sep; 250(2):462-5. PubMed ID: 9753653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between preoperative urine cultures and prostatic gland cultures in patients treated for benign prostatic hyperplasia].
    Soler Soler JL; Hidalgo Domínguez MR; Martínez Torres JL; Zuluaga Gómez A; Nogueras Ocaña M; Lardelli Claret P; Liébana Ureña J; Saharour G
    Actas Urol Esp; 1999 Jun; 23(6):505-17. PubMed ID: 10464959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of urovirulence genes cnf, hlyD, sfa/foc, and papGIII in fecal Escherichia coli from healthy dogs and their owners.
    Stenske KA; Bemis DA; Gillespie BE; Oliver SP; Draughon FA; Matteson KJ; Bartges JW
    Am J Vet Res; 2009 Nov; 70(11):1401-6. PubMed ID: 19878023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of NKX3.1 in benign prostatic hyperplasia.
    Irer B; Toylu A; Aslan G; Celebi I; Yorukoglu K; Atabey N
    Urology; 2009 May; 73(5):1140-4. PubMed ID: 18597829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms.
    Sfanos KS; Sauvageot J; Fedor HL; Dick JD; De Marzo AM; Isaacs WB
    Prostate; 2008 Feb; 68(3):306-20. PubMed ID: 18163428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expressions of bacterial 16S rRNA, IL-1beta, TNF-alpha and NGF in prostate tissues].
    Xie H; Huang HC; Yang YR; He QX; Zhu QJ; Chen JO
    Zhonghua Nan Ke Xue; 2010 Jan; 16(1):40-3. PubMed ID: 20180403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
    Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
    Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.